ArticleAnnals of translational medicine2019
Significant association of CD4
Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis.Journal of cancer research and clinical oncology · 2023Pooled it
- Article
- Current cell therapies for systemic lupus erythematosus.Stem cells translational medicine · 2024Review
- Circulating lymphocyte subpopulations in patients with systemic lupus erythematosus and their correlation with disease activity.Clinical and experimental medicine · 2023Article
- Elevation of Metrnβ and Its Association with Disease Activity in Systemic Lupus Erythematosus.International journal of molecular sciences · 2023Article
- A decreased number of circulating regulatory T cells is associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.Immunity, inflammation and disease · 2022Article
- Article
- New biomarkers in SLE: from bench to bedside.Rheumatology (Oxford, England) · 2020Review
- Protective effect of FOXP3-mediated miR-146b-5p/Robo1/NF-κB system on lipopolysaccharide-induced acute lung injury in mice.Annals of translational medicine · 2020Article
- Association between systemic lupus erythematosus and lung cancer: results from a pool of cohort studies and Mendelian randomization analysis.Journal of thoracic disease · 2020Article
- Advances in the role of helper T cells in autoimmune diseases.Chinese medical journal · 2020Review
- Non-Coding RNAs in CD4Frontiers in immunology · 2020Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRegulatory T (Treg) cells are one of the important mechanisms in maintaining self-tolerance and immune homeostasis. CD4
methodsThe peripheral blood T cells (PBMCs) from patients with SLE and healthy controls were isolated, and followed by the isolation of CD3
resultsCD4
conclusionsThere is clear and definite evidence from the present study indicating the important role of CD4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.